Although core needle biopsy has been shown to be an accurate means of diagnosing lung malignancies, there is relatively little information in the literature about its utility in diagnosing specific non-malignant conditions. We reviewed the pathologic findings in 159 core needle biopsies showing benign changes in order to determine the types of processes that can be diagnosed by this technique and the factors that influence accuracy and specificity. There were 155 patients ranging in age from 3 to 86 years (mean 58). Nodules or masses were present radiologically in most. They ranged from 0.5 to 8.0 cm (mean 1.65 cm) in size and 80% measured 2.0 cm or less. Twenty percent were spiculated, and positron emission tomography scans were positive in 48 of 56 cases tested (30% of total). Specific diagnoses were established in 122 (77%) of 159 core needle biopsies, while 24 (15%) were nonspecific and 13 (8%) were nonrepresentative. The most common specific diagnoses were necrotizing granulomatous inflammation (45), scar (28), organizing pneumonia (13), and benign neoplasms (11). A mixture of interstitial fibrosis and chronic inflammation (16) was the most common nonspecific diagnosis. A specific diagnosis was significantly more likely in biopsies with 3 or more cores or with a core length of more than 1 cm. Malignancy was diagnosed on a subsequent biopsy in only one case, and the initial biopsy in that case showed non-specific chronic inflammation and fibrosis. Our findings confirm that core needle biopsy is an accurate method of diagnosing benign lung lesions, yielding specific diagnoses in the majority.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.humpath.2010.04.014 | DOI Listing |
Cytopathology
January 2025
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
Objective: An accurate fine-needle aspiration (FNA) diagnosis of adrenal lesions may be challenging. This study was to investigate roles of imaging guidance, rapid on-site evaluation (ROSE) and additional tissue sampling in FNA diagnosis of adrenal lesions.
Methods: Adrenal FNA cases were retrieved from pathology archive.
JTO Clin Res Rep
February 2025
Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York.
Introduction: Limited information exists on next-generation sequencing (NGS) success for lung tumors of 30 mm or less. We aimed to compare NGS success rates across biopsy techniques for these tumors, assess DNA sequencing quality, and verify reliability against surgical resection results.
Methods: We used data from the Initiative for Early Lung Cancer Research on Treatment study, including patients with lung tumors measuring 30 mm or less who had surgery and NGS on biopsies since 2016.
Ann Surg Oncol
January 2025
Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Background: Atypical ductal hyperplasia (ADH) is a benign proliferative breast lesion. Surgical excision of ADH is often recommended to rule out underlying malignant disease.
Objective: The aim of this study was to evaluate the trends in ADH upgrade rates over time and identify the impact of magnetic resonance imaging (MRI) use on upgrade rates.
Biomed Microdevices
January 2025
Institute of Industrial Science, The University of Tokyo, Meguro-Ku, 153-8505, Tokyo, Japan.
Recently, photodynamic therapy (PDT) which involves a photosensitizer (PS), a special drug activated by light, and light irradiation has been widely used in treating various skin diseases such as port-wine stain as well as cancers such as melanoma and non-melanoma skin cancers. PDT comprises two general steps: the introduction of PS into the body or a specific spot to be treated, and the irradiation process using a light source with a specific wavelength to excite the PS. Although PDT is gaining great attention owing to its potential as a targeted approach in the treatment of skin cancers, several limitations still exist for practical use.
View Article and Find Full Text PDFAnn Surg Oncol
January 2025
Department of Radiology, University of Washington, Seattle, WA, USA.
Background: Ductal carcinoma in situ (DCIS) is overtreated, in part because of inability to predict which DCIS cases diagnosed at core needle biopsy (CNB) will be upstaged at excision. This study aimed to determine whether quantitative magnetic resonance imaging (MRI) features can identify DCIS at risk of upstaging to invasive cancer.
Methods: This prospective observational clinical trial analyzed women with a diagnosis of DCIS on CNB.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!